These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 15451788)

  • 1. Optimal windows of statin use for immediate infarct limitation: 5'-nucleotidase as another downstream molecule of phosphatidylinositol 3-kinase.
    Sanada S; Asanuma H; Minamino T; Node K; Takashima S; Okuda H; Shinozaki Y; Ogai A; Fujita M; Hirata A; Kim J; Asano Y; Mori H; Tomoike H; Kitamura S; Hori M; Kitakaze M
    Circulation; 2004 Oct; 110(15):2143-9. PubMed ID: 15451788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vesnarinone limits infarct size via adenosine-dependent mechanisms in the canine heart.
    Kitakaze M; Minamino T; Funaya H; Node K; Shinozaki Y; Mori H; Hori M
    Circulation; 1997 Apr; 95(8):2108-14. PubMed ID: 9133521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pravastatin restored the infarct size-limiting effect of ischemic preconditioning blunted by hypercholesterolemia in the rabbit model of myocardial infarction.
    Ueda Y; Kitakaze M; Komamura K; Minamino T; Asanuma H; Sato H; Kuzuya T; Takeda H; Hori M
    J Am Coll Cardiol; 1999 Dec; 34(7):2120-5. PubMed ID: 10588233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of ecto-5'-nucleotidase by protein kinase C and its role in ischaemic tolerance in the canine heart.
    Node K; Kitakaze M; Minamino T; Tada M; Inoue M; Hori M; Kamada T
    Br J Pharmacol; 1997 Jan; 120(2):273-81. PubMed ID: 9117120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Infarct size-limiting effect of ischemic preconditioning is blunted by inhibition of 5'-nucleotidase activity and attenuation of adenosine release.
    Kitakaze M; Hori M; Morioka T; Minamino T; Takashima S; Sato H; Shinozaki Y; Chujo M; Mori H; Inoue M
    Circulation; 1994 Mar; 89(3):1237-46. PubMed ID: 8124812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SCH 79797, a selective PAR1 antagonist, limits myocardial ischemia/reperfusion injury in rat hearts.
    Strande JL; Hsu A; Su J; Fu X; Gross GJ; Baker JE
    Basic Res Cardiol; 2007 Jul; 102(4):350-8. PubMed ID: 17468933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of activation of protein kinase C in the infarct size-limiting effect of ischemic preconditioning through activation of ecto-5'-nucleotidase.
    Kitakaze M; Node K; Minamino T; Komamura K; Funaya H; Shinozaki Y; Chujo M; Mori H; Inoue M; Hori M; Kamada T
    Circulation; 1996 Feb; 93(4):781-91. PubMed ID: 8641008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein tyrosine kinase is not involved in the infarct size-limiting effect of ischemic preconditioning in canine hearts.
    Kitakaze M; Node K; Asanuma H; Takashima S; Sakata Y; Asakura M; Sanada S; Shinozaki Y; Mori H; Kuzuya T; Hori M
    Circ Res; 2000 Aug; 87(4):303-8. PubMed ID: 10948064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A New Therapeutic Modality for Acute Myocardial Infarction: Nanoparticle-Mediated Delivery of Pitavastatin Induces Cardioprotection from Ischemia-Reperfusion Injury via Activation of PI3K/Akt Pathway and Anti-Inflammation in a Rat Model.
    Nagaoka K; Matoba T; Mao Y; Nakano Y; Ikeda G; Egusa S; Tokutome M; Nagahama R; Nakano K; Sunagawa K; Egashira K
    PLoS One; 2015; 10(7):e0132451. PubMed ID: 26167913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of activation of ectosolic 5'-nucleotidase in the cardioprotection mediated by opening of K+c channels.
    Kitakaze M; Minamino T; Node K; Komamura K; Shinozaki Y; Chujo M; Mori H; Inoue M; Hori M; Kamada T
    Am J Physiol; 1996 May; 270(5 Pt 2):H1744-56. PubMed ID: 8928882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Opioid-induced cardioprotection occurs via glycogen synthase kinase beta inhibition during reperfusion in intact rat hearts.
    Gross ER; Hsu AK; Gross GJ
    Circ Res; 2004 Apr; 94(7):960-6. PubMed ID: 14976126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Erythropoietin just before reperfusion reduces both lethal arrhythmias and infarct size via the phosphatidylinositol-3 kinase-dependent pathway in canine hearts.
    Hirata A; Minamino T; Asanuma H; Sanada S; Fujita M; Tsukamoto O; Wakeno M; Myoishi M; Okada K; Koyama H; Komamura K; Takashima S; Shinozaki Y; Mori H; Tomoike H; Hori M; Kitakaze M
    Cardiovasc Drugs Ther; 2005 Jan; 19(1):33-40. PubMed ID: 15883754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ecto-5'-nucleotidase mediates infarct size-limiting effect by ischemic preconditioning in the rabbit heart.
    Komamura K; Kitakaze M; Funaya H; Ueda Y; Node K; Minamino T; Kurihara T; Hori M
    J Cardiovasc Pharmacol; 1997 Dec; 30(6):775-83. PubMed ID: 9436817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Critical role of PI3-kinase/Akt activation in the PARP inhibitor induced heart function recovery during ischemia-reperfusion.
    Kovacs K; Toth A; Deres P; Kalai T; Hideg K; Gallyas F; Sumegi B
    Biochem Pharmacol; 2006 Feb; 71(4):441-52. PubMed ID: 16337154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of ErbB2-PI3K/Akt signaling prevents zinc pyrithione-induced cardioprotection during ischemia/reperfusion.
    Thokala S; Inapurapu S; Bodiga VL; Vemuri PK; Bodiga S
    Biomed Pharmacother; 2017 Apr; 88():309-324. PubMed ID: 28119233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methotrexate and MX-68, a new derivative of methotrexate, limit infarct size via adenosine-dependent mechanisms in canine hearts.
    Asanuma H; Sanada S; Ogai A; Minamino T; Takashima S; Asakura M; Ogita H; Shinozaki Y; Mori H; Node K; Tomoike H; Hori M; Kitakaze M
    J Cardiovasc Pharmacol; 2004 Apr; 43(4):574-9. PubMed ID: 15085069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alpha 1-adrenoceptor activation mediates the infarct size-limiting effect of ischemic preconditioning through augmentation of 5'-nucleotidase activity.
    Kitakaze M; Hori M; Morioka T; Minamino T; Takashima S; Sato H; Shinozaki Y; Chujo M; Mori H; Inoue M
    J Clin Invest; 1994 May; 93(5):2197-205. PubMed ID: 8182151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postconditioning: a form of "modified reperfusion" protects the myocardium by activating the phosphatidylinositol 3-kinase-Akt pathway.
    Tsang A; Hausenloy DJ; Mocanu MM; Yellon DM
    Circ Res; 2004 Aug; 95(3):230-2. PubMed ID: 15242972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Superoxide dismutase enhances ischemia-induced reactive hyperemic flow and adenosine release in dogs. A role of 5'-nucleotidase activity.
    Kitakaze M; Hori M; Takashima S; Iwai K; Sato H; Inoue M; Kitabatake A; Kamada T
    Circ Res; 1992 Sep; 71(3):558-66. PubMed ID: 1499105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Darbepoetin alfa protects the rat heart against infarction: dose-response, phase of action, and mechanisms.
    Baker JE; Kozik D; Hsu AK; Fu X; Tweddell JS; Gross GJ
    J Cardiovasc Pharmacol; 2007 Jun; 49(6):337-45. PubMed ID: 17577097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.